Abstract
Hepatocellular carcinoma (HCC) is one of the most common and lethal tumors worldwide. HCC management depends on reliable biomarkers for screening, diagnosing and monitoring the disease, as well as predicting response to therapy. Ultrasound has been the established standard technique in the diagnosis and follow-up of HCC. However, imaging techniques have their limitations, especially early…